Market Currents
Mylan (MYL -2.1%) sues the FDA seeking relief over the 180-day exclusivity granted by the agency...
-
Thursday, April 5, 2012, 1:01 PM ETMylan (MYL -2.1%) sues the FDA seeking relief over the 180-day exclusivity granted by the agency to Teva Pharmaceuticals (TEVA +0.4%) over its generic Provigil. Attorneys repping the firm filed the suit at double-speed with the launch of the narcolepsy-fighting drug just crossing the wires less than a week ago.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
